Cultivating children’s creativity

Kibooco (short for “Kids Book Company”) Interactive is a technology startup whose aim is to encourage children’s creativity by developing an online e-book tool where children can create their own virtual and physical storybooks.  Being a small company with limited research resources, Kibooco reached out to the Mitacs-Accelerate program for support and expertise – and found Allen.

Canadian pharmaceutical company given start-up strength

However, the cost of research and development of natural health products is often impossibly steep as the products must be rigorously tested and proven before they can be placed on store shelves.

With this challenge ahead of them, the Alberta “phyto-pharmaceutical” biotech company, SinoVeda, turned to Mitacs-Accelerate to assist in the advanced testing of its latest natural calcium supplement which is currently undergoing clinical trials.

Collaborating on a vaccine for cancer

The company is developing a novel cancer vaccine based on a specific antigen and needed the research expertise to help them understand, at a molecular level, how that antigen is expressed in different types of cancer. They turned to Dalhousie postdoctoral fellow Olga Hrytsenko for insight. Olga’s 17 years of molecular biology experience is the “perfect fit” for the project says Marianne Stanford, Director of Research, at Immunovaccine.

Intern’s innovation accelerates global expansion!

For Cyborg Trading Systems (CTS) – a financial technology services company that serves an international network of banks, brokers and professional traders – keeping ahead of competition is absolutely essential.  Battling huge enterprises like Thomson Reuters, Bloomberg and Goldman Sachs would seem an almost impossible task for a Canadian SME.  With the cost of infrastructure, technology and global employees rising by the second, Lukez is always looking for any and all opportunities to innovate.

Award Winner Interview: SayedMasoud Hashemi Amroabadi

The research led to a 78% reduction in CT image noise which facilitates a corresponding decrease in the patient radiation exposure required for high quality CT images, saving patients from the potentially harmful effects of X-ray dose radiation.  Below is an exclusive interview with Mr. Hashemi, who won the Mitacs Award for Novelty in Application, as presented by the Honourable Gail Shea, Minister of National Revenue at the 2nd Annual Mitacs Awards Reception, held November 28th in Ottawa.

Award Winner Interview: Joanna Triscott

Because of this research, BC Children’s Hospital can how examine all new cases of pediatric brain tumors throughout the entirety of Western Canada with precision and accuracy – thus reducing the (often excessive) intensity of treatment for children with cancer while still effectively treating the disease.  Below is an exclusive interview with Ms.

Making security systems smarter

It was Dr. Janice Singer, an IRAP-Industry Technology Advisor, who awarded Rafael the 1st prize in the poster competition and saw the great potential in Rafael’s and Larus' mutual interest in wireless sensors and robot networks.

Magical Innovation in 3D

With new broadcast television channels playing stereoscopic content, there is an increasing need for stereoscopic animated shows and commercials.

Landing a dream job through Mitacs-Accelerate

For the last year and a half, Side Effects Software had been developing a web-based marketplace for highly-customizable 3D content. Similar to Apple’s App Store or Android’s Market, the company’s Orbolt™ Smart Asset Store is an application marketplace where digital artists can purchase smart 3D assets. Entering the e-commerce marketplace for the first time meant the company faced a number of unique challenges. They turned to Yeleiny through Mitacs-Accelerate for web performance expertise.

Mitacs Accelerate partnership leads to development of high-tech diabetic insoles

By 2020, it is estimated that diabetes will cost the Canadian healthcare system $16.9 billion a year. In response, Calgary-based Orpyx Medical Technologies is developing a product that is garnering the attention of the diabetes technology community. The SurroSense Rx is a pressure sensitive insole that relays plantar pressure information to a wristwatch, notifying the user when damage is being done to their feet so that behavior can be modified to avoid complications.

Pages